[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
For Authors::
For Reviewers::
Subscription::
News & Events::
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE

:: Volume 22, Issue 3 (7-2024) ::
Int J Radiat Res 2024, 22(3): 767-770 Back to browse issues page
Clinical efficacy and safety of laparoscopic radical surgery and radiotherapy for the treatment of early-stage gallbladder cancer
A.S. GuiFen Wei , H. Ao , H. Yan , J. Huang
Department of Hepatobiliary and Pancreatic Surgery, The Second People's Hospital of Tongxiang, Zhejiang, 314511, China , Dr.med.he1234@gmail.com
Abstract:   (640 Views)
Background: Gallbladder cancer (GBC) is a challenging malignancy with poor prognosis. Although radical cholecystectomy is the accepted surgical approach, the safety and effectiveness of laparoscopic radical surgery and radiotherapy are remained under-studied. Materials and Methods: A single-center, prospective study was conducted from May 2020 to May 2023. One hundred patients diagnosed with early-stage GBC were categorized into two groups: an Intervention Group (n=50) that underwent laparoscopic radical surgery and radiotherapy, and a Control Group (n=50) that received conventional open surgery. Key indicators such as surgical conditions, postoperative rehabilitation, and survival rates were evaluated in both groups. Results: The Intervention Group demonstrated superior surgical outcomes, including a significantly reduced surgical bleeding volume (198.5±23.1 vs. 286.3±18.7 ml, P-value <0.001), shorter operative duration (168.6±64.8 vs. 261.1±55.3 min, P-value <0.001), and smaller incision length (1.1±0.3 vs. 8.2±1.2 cm, P-value <0.001). Postoperatively, the Intervention Group also showed marked improvements in hospital stay duration (7.5±1.4 vs. 9.3±2.9 days, P-value <0.001), time to first ambulation (2.1±0.8 vs. 6.9±1.1 days, P-value <0.001), and gastric function recovery (2.2±0.6 vs. 3.5±1.3 days, P-value <0.001). Complication rates were lower, with abdominal infections observed in 0 cases in the Intervention Group compared to 4 cases (8%) in the Control Group (P-value:0.041). Long-term follow-up indicated a trend toward better 3-year survival rates in the Intervention Group (84% vs 68%, P-value: 0.061). Conclusion: Our findings suggest that laparoscopic radical cholecystectomy is a viable and safe option for treating early-stage GBC, aligning with existing literature that advocates for minimally invasive surgical approaches.
Keywords: Early-stage gallbladder cancer, Laparoscopic radical cholecystectomy, postoperative outcomes, prospective cohort study, surgical Efficacy.
Full-Text [PDF 466 kb]   (184 Downloads)    
Type of Study: Short Report | Subject: Radiation Biology
References
1. Zhang W and Che X (2021) Feasibility and safety of laparoscopic treatment for early and T3 stage gallbladder cancer: a systematic review. Sur Lapa Endo Percut Techniques, 31(1): 113-23. [DOI:10.1097/SLE.0000000000000852]
2. Byun Y, Choi YJ, Kang JS, Han Y, Kim H, Kwon W, et al. (2020) Early outcomes of robotic extended cholecystectomy for the treatment of gallbladder cancer. J Hepa‐Bili‐Panc Sci, 27(6): 324-30. [DOI:10.1002/jhbp.717]
3. Han HS, Yoon YS, Agarwal AK, Belli G, Itano O, Gumbs AA, et al. (2019) Laparoscopic Surgery for Gallbladder Cancer: An Expert Consensus Statement. Dig Surg, 36(1): 1-6. [DOI:10.1159/000486207]
4. Moon J, Shin YC, Heo T-G, Choi PW, Kim JI, Jung SW, et al. (2019) Differentiation of gallbladder adenomyomatosis from early-stage gallbladder cancer before surgery. An Hepa-Bili-Panc Sur, 23(4): 334-8. [DOI:10.14701/ahbps.2019.23.4.334]
5. Chaudhari VA, Bhandare MS, Shrikhande SV (2021) Incidental gallbladder cancer-current recommendations and management protocols. Indian Journal of Surgery, 83(4): 845-51. [DOI:10.1007/s12262-021-02828-9]
6. Anjali K, Singh D, Kumar P, Kumar T, Narayan G, Singh S (2021) PARP1 rs1136410 (A/G) polymorphism is associated with early age of onset of gallbladder cancer. European Journal of Cancer Prevention, 31(4): 311-7. [DOI:10.1097/CEJ.0000000000000708]
7. Goel M, Pandrowala S, Patel P, Patkar S (2022) Node positivity in T1b gallbladder cancer: A high volume centre experience. European Journal of Surgical Oncology, 48(7): 1585-9. [DOI:10.1016/j.ejso.2022.03.013]
8. Rizzo A and Brandi G (2021) Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer. Expert Review of Gastroenterology & Hepatology, 15(5): 547-54. [DOI:10.1080/17474124.2021.1890031]
9. Pai SS-T, Lin H-H, Cheng H-H, Huang S-C, Lin C-C, Lan Y-T, et al. (2022) Clinical outcome of local treatment and radical resection for pT1 rectal cancer. Int J Colorect Dis, 37(8): 1845-51. [DOI:10.1007/s00384-022-04220-9]
10. Porta C, Cosmai L, Leibovich BC, Powles T, Gallieni M, Bex A (2019) The adjuvant treatment of kidney cancer: a multidisciplinary outlook. Nature Reviews Nephrology, 15(7): 423-33. [DOI:10.1038/s41581-019-0131-x]
11. Scherman P, Syk I, Holmberg E, Naredi P, Rizell M. (2020) Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer. BJS open, 4(1): 118-32. [DOI:10.1002/bjs5.50237]
12. Yuza K, Sakata J, Prasoon P, Hirose Y, Ohashi T, Toge K, et al. (2020) Long-term outcomes of surgical resection for T1b gallbladder cancer: an institutional evaluation. BMC Cancer, 20(1): 20. [DOI:10.1186/s12885-019-6507-2]
13. Kimpel O, Bedrose S, Megerle F, Berruti A, Terzolo M, Kroiss M, et al. (2021) Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study. British Journal of Cancer, 125(9): 1233-8. [DOI:10.1038/s41416-021-01513-8]
14. Witjes JA, Galsky MD, Gschwend JE, Broughton E, Braverman J, Nasroulah F, et al. (2022) Health-related quality of life with adjuvant nivolumab after radical resection for high-risk muscle-invasive urothelial carcinoma: results from the phase 3 CheckMate 274 trial. European Urology Oncology, 5(5): 553-63. [DOI:10.1016/j.euo.2022.02.003]
15. Deo KB, Kumar R, Tiwari G, Kumar H, Verma GR, Singh H (2020) Surgical management of hepatic hydatid cysts-conservative versus radical surgery. HPB, 22(10): 1457-62. [DOI:10.1016/j.hpb.2020.03.003]
16. Zhang LX, Li YS, Wu WW, Chen G, Liu YB (2020) Safety of laparoscopic cholecystectomy for gallbladder cancer: a meta-analysis. Zhonghua Yi Xue Za Zhi, 100(42): 3342-9.
17. Nian X, Ye H, Zhang W, Zhang K, Gao X, Yang B, et al. (2022) Propensity-matched pair analysis of safety and efficacy between laparoscopic and open radical nephrectomy for the treatment of large renal masses (>10 cm): a retrospective cohort study. Transl Androl Urol, 11(8): 1148-56. [DOI:10.21037/tau-22-449]
18. Long J, Wang L, Dong N, Bai X, Chen S, Sun S, et al. (2022) Robotic-assisted versus standard laparoscopic radical cystectomy in bladder cancer: A systematic review and meta-analysis. Front Oncol, 12: 1024739. [DOI:10.3389/fonc.2022.1024739]
19. Pehlivanoglu B, Akkas G, Memis B, Basturk O, Reid MD, Saka B, et al. (2023) Reappraisal of T1b gallbladder cancer (GBC): clinicopathologic analysis of 473 in situ and invasive GBCs and critical review of the literature highlights its rarity, and that it has a very good prognosis. Virchows Archiv, 482(2): 311-23. [DOI:10.1007/s00428-022-03482-6]
20. Søreide K, Guest R, Harrison E, Kendall T, Garden O, Wigmore S (2019) Systematic review of management of incidental gallbladder cancer after cholecystectomy. Journal of British Surgery, 106(1): 32-45. [DOI:10.1002/bjs.11035]
21. Luo C, Liu M, Li X (2018) Efficacy and safety outcomes of robotic radical hysterectomy in Chinese older women with cervical cancer compared with laparoscopic radical hysterectomy. BMC Womens Health, 18(1): 61. [DOI:10.1186/s12905-018-0544-x]
22. Kim B-H, Kim S-H, Song I-S, Chun G-S (2019) The appropriate surgical strategy for T1b gallbladder cancer incidentally diagnosed after a simple cholecystectomy. An Hepa-Bili-Panc Sur, 23(4): 327-33. [DOI:10.14701/ahbps.2019.23.4.327]
23. Homsy P, Blomqvist C, Heiskanen I, Vikatmaa L, Tukiainen E, Numminen K, et al. (2020) Multidisciplinary oncovascular surgery is safe and effective in the treatment of intra-abdominal and retroperitoneal sarcomas: a retrospective single centre cohort study and a comprehensive literature review. Eur J Vascu Endovascu Sur, 60(5): 752-63. [DOI:10.1016/j.ejvs.2020.05.029]
24. Erdogan O, Parlakgumus A, Kulahci O, Irkorucu O (2021) Abdominal wall reconstruction for desmoid tumors following radical resection from the abdominoplasty incision: Case report. Nigerian Journal of Clinical Practice, 24(7): 1100-2. [DOI:10.4103/njcp.njcp_246_20]
25. Wang X, Lin Y, Lu Z-L, Li J (2020) Circular RNA circ-MTO1 serves as a novel potential diagnostic and prognostic biomarker for gallbladder cancer. Eur Rev Med Pharm Sci, 24(16): 8359-8366.
26. Rawla P, Sunkara T, Thandra KC, Barsouk A (2019) Epidemiology of gallbladder cancer. Clin Exp Hepa, 5(2): 93-102. [DOI:10.5114/ceh.2019.85166]
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

GuiFen Wei A, Ao H, Yan H, Huang J. Clinical efficacy and safety of laparoscopic radical surgery and radiotherapy for the treatment of early-stage gallbladder cancer. Int J Radiat Res 2024; 22 (3) :767-770
URL: http://ijrr.com/article-1-5664-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 22, Issue 3 (7-2024) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.06 seconds with 48 queries by YEKTAWEB 4710